News

The U.S. FDA granted EUA for investigational bamlanivimab (LY-CoV555) 700 mg and etesevimab (LY-CoV016) 1400 mg together, Eli Lilly and Company announced. This therapy is authorized for the treatment of mild to moderate COVID-19 in patients aged 12 and...

Godrej & Boyce, the flagship company of the Godrej Group, has been contributing to making India self-reliant since its inception. Taking a step further towards building the nation’s healthcare infrastructure, Godrej & Boyce through its business unit Godrej Appliances,...

Vaccine exports get a shot in the arm from global drug demand. Pune’s Serum Institute of India (SII) has shipped 30 million doses of the AstraZeneca-Oxford vaccine to 20 countries. Bharat Biotech is all set to start exports to...

Ocugen, Inc., a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19, and Bharat Biotech, a global leader in vaccine innovation, announced they have entered into a...

Iran began its Covid-19 vaccination campaign on Tuesday using Russia's Sputnik V jab to fight the Middle East's deadliest outbreak of the illness. The first doses were given to doctors and nurses at Imam Khomeini hospital in the capital Tehran,...

Business intelligence platform Suppleye has launched a free tool to help pharmaceutical professionals stay on top of critical supply market news. Suppleye provides users with an intelligent resource to monitor key market news within the pharmaceutical sector and track sentiment....

Vir Biotechnology, Inc. announced the publication of new research characterizing a novel site of vulnerability on the SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) spike protein – specifically the N-terminal domain (NTD). The study findings were made available online on...